QYR Market Research Global Donepezil market research | Page 4

QYResearch
The classification of Donepezil includes 5mg, 10mg and 23mg,
and the proportion of 10mg in 2017 is about 48%.
North America is the largest consumption region of Donepezil,
with a sales market share nearly 37% in 2017. Europe is the
second largest consumption region of Donepezil, enjoying
Sales market share nearly 29% in 2017.
Donepezil was developed by Eisai and Pfizer and is sold as a
generic by multiple suppliers. Donepezil acts as a centrally
acting reversible acetylcholinesterase inhibitor.
w w w. q y r e s e a r c h . c o m